Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Liabilities and Shareholders Equity (2020 - 2026)

Sight Sciences has reported Liabilities and Shareholders Equity over the past 6 years, most recently at $115.3 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 19.28% year-over-year to $115.3 million; the TTM value through Dec 2025 reached $483.2 million, down 18.34%, while the annual FY2025 figure was $115.3 million, 19.28% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $115.3 million at Sight Sciences, down from $116.3 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $291.0 million in Q3 2021 and troughed at $52.5 million in Q2 2021.
  • A 5-year average of $176.9 million and a median of $166.7 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 358.48% in 2022 and later fell 23.96% in 2023.
  • Year by year, Liabilities and Shareholders Equity stood at $280.2 million in 2021, then fell by 23.95% to $213.1 million in 2022, then fell by 21.79% to $166.7 million in 2023, then fell by 14.29% to $142.8 million in 2024, then fell by 19.28% to $115.3 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for SGHT at $115.3 million in Q4 2025, $116.3 million in Q3 2025, and $122.0 million in Q2 2025.